Covalent Group, Inc. Changes Name To Encorium Group, Inc.

WAYNE, Pa.--(BUSINESS WIRE)--Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, announced today that its common stock began trading on NASDAQ under the ticker symbol “ENCO” this morning. The change in the Company’s name to Encorium Group, Inc. was recently approved at its Annual Meeting of Shareholders on October 20, 2006.